001     274476
005     20240229154934.0
024 7 _ |a 10.1016/j.dld.2023.02.023
|2 doi
024 7 _ |a pmid:36973108
|2 pmid
024 7 _ |a 1590-8658
|2 ISSN
024 7 _ |a 1878-3562
|2 ISSN
024 7 _ |a altmetric:144382779
|2 altmetric
037 _ _ |a DKFZ-2023-00621
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Nodari, Ylenia
|b 0
245 _ _ |a Genetic and non-genetic risk factors for early-onset pancreatic cancer.
260 _ _ |a [Erscheinungsort nicht ermittelbar]
|c 2023
|b Saunders
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1698150482_25267
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2023 Oct;55(10):1417-1425
520 _ _ |a Early-onset pancreatic cancer (EOPC) represents 5-10% of all pancreatic ductal adenocarcinoma (PDAC) cases, and the etiology of this form is poorly understood. It is not clear if established PDAC risk factors have the same relevance for younger patients. This study aims to identify genetic and non-genetic risk factors specific to EOPC.A genome-wide association study was performed, analysing 912 EOPC cases and 10 222 controls, divided into discovery and replication phases. Furthermore, the associations between a polygenic risk score (PRS), smoking, alcohol consumption, type 2 diabetes and PDAC risk were also assessed.Six novel SNPs were associated with EOPC risk in the discovery phase, but not in the replication phase. The PRS, smoking, and diabetes affected EOPC risk. The OR comparing current smokers to never-smokers was 2.92 (95% CI 1.69-5.04, P = 1.44 × 10-4). For diabetes, the corresponding OR was 14.95 (95% CI 3.41-65.50, P = 3.58 × 10-4).In conclusion, we did not identify novel genetic variants associated specifically with EOPC, and we found that established PDAC risk variants do not have a strong age-dependent effect. Furthermore, we add to the evidence pointing to the role of smoking and diabetes in EOPC.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Early onset
|2 Other
650 _ 7 |a GWAS
|2 Other
650 _ 7 |a Pancreatic cancer
|2 Other
650 _ 7 |a Risk factor
|2 Other
700 1 _ |a Gentiluomo, Manuel
|b 1
700 1 _ |a Mohelnikova-Duchonova, Beatrice
|b 2
700 1 _ |a Kreivenaite, Edita
|b 3
700 1 _ |a Milanetto, Anna Caterina
|b 4
700 1 _ |a Skieceviciene, Jurgita
|b 5
700 1 _ |a Landi, Stefano
|b 6
700 1 _ |a Lawlor, Rita T
|b 7
700 1 _ |a Petrone, Maria Chiara
|b 8
700 1 _ |a Arcidiacono, Paolo Giorgio
|b 9
700 1 _ |a Lovecek, Martin
|b 10
700 1 _ |a Gazouli, Maria
|b 11
700 1 _ |a Bijlsma, Maarten F
|b 12
700 1 _ |a Morelli, Luca
|b 13
700 1 _ |a Kiudelis, Vytautas
|b 14
700 1 _ |a Tacelli, Matteo
|b 15
700 1 _ |a Zanette, Dalila Lucíola
|b 16
700 1 _ |a Soucek, Pavel
|b 17
700 1 _ |a Uzunoglu, Faik
|b 18
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 19
|u dkfz
700 1 _ |a Izbicki, Jakob
|b 20
700 1 _ |a Boggi, Ugo
|b 21
700 1 _ |a Pezzilli, Raffaele
|b 22
700 1 _ |a Mambrini, Andrea
|b 23
700 1 _ |a Pasquali, Claudio
|b 24
700 1 _ |a van Laarhoven, Hanneke W
|b 25
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 26
|u dkfz
700 1 _ |a Cavestro, Giulia Martina
|b 27
700 1 _ |a Sperti, Cosimo
|b 28
700 1 _ |a Loos, Martin
|b 29
700 1 _ |a Latiano, Anna
|b 30
700 1 _ |a Erőss, Bálint
|b 31
700 1 _ |a Oliverius, Martin
|b 32
700 1 _ |a Johnson, Theron
|0 P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa
|b 33
|u dkfz
700 1 _ |a Basso, Daniela
|b 34
700 1 _ |a Neoptolemos, John P
|b 35
700 1 _ |a Aoki, Mateus Nóbrega
|b 36
700 1 _ |a Greenhalf, William
|b 37
700 1 _ |a Vodicka, Pavel
|b 38
700 1 _ |a Archibugi, Livia
|b 39
700 1 _ |a Vanella, Giuseppe
|b 40
700 1 _ |a Lucchesi, Maurizio
|b 41
700 1 _ |a Talar-Wojnarowska, Renata
|b 42
700 1 _ |a Jamroziak, Krzysztof
|b 43
700 1 _ |a Saeedi, Mohammed Al
|b 44
700 1 _ |a van Eijck, Casper H J
|b 45
700 1 _ |a Kupcinskas, Juozas
|b 46
700 1 _ |a Hussein, Tamás
|b 47
700 1 _ |a Puzzono, Marta
|b 48
700 1 _ |a Bunduc, Stefania
|b 49
700 1 _ |a Götz, Mara
|b 50
700 1 _ |a Carrara, Silvia
|b 51
700 1 _ |a Szentesi, Andrea
|b 52
700 1 _ |a Tavano, Francesca
|b 53
700 1 _ |a Moz, Stefania
|b 54
700 1 _ |a Hegyi, Péter
|b 55
700 1 _ |a Luchini, Claudio
|b 56
700 1 _ |a Capurso, Gabriele
|b 57
700 1 _ |a Perri, Francesco
|b 58
700 1 _ |a Ermini, Stefano
|b 59
700 1 _ |a Theodoropoulos, George
|b 60
700 1 _ |a Capretti, Giovanni
|b 61
700 1 _ |a Palmieri, Orazio
|b 62
700 1 _ |a Ginocchi, Laura
|b 63
700 1 _ |a Furbetta, Niccolò
|b 64
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 65
|u dkfz
700 1 _ |a Campa, Daniele
|b 66
773 _ _ |a 10.1016/j.dld.2023.02.023
|g p. S1590865823005145
|0 PERI:(DE-600)2061359-3
|n 10
|p 1417-1425
|t Digestive and liver disease
|v 55
|y 2023
|x 1590-8658
909 C O |p VDB
|o oai:inrepo02.dkfz.de:274476
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 26
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 33
|6 P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 65
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-24
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b DIGEST LIVER DIS : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-24
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21